Table of Content

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Bovine Blood Plasma Derivatives Market

4. Market Overview
    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution/Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, 2017–2031

5. Key Insights
    5.1. Pipeline Analysis
    5.2. Key Product/Brand Analysis
    5.3. Key Mergers & Acquisitions
    5.4. COVID-19 Pandemic Impact on Industry

6. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Derivative Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Derivative Type, 2017–2031
        6.3.1. Immunoglobulin
        6.3.2. Fibrinogen
        6.3.3. Bovine Serum Albumin
        6.3.4. Fetal Bovine Serum
        6.3.5. Thrombin
        6.3.6. Transferrin
        6.3.7. Newborn Calf Serum
        6.3.8. Others
    6.4. Market Attractiveness Analysis, by Derivative Type

7. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Application
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Application, 2017–2031
        7.3.1. Pharmaceutical Industry
        7.3.2. Diagnostics Industry
        7.3.3. Cell Culture/ Biotechnology
        7.3.4. Research and Development
        7.3.5. Food Industry
        7.3.6. Cosmetic Industry
        7.3.7. Others
    7.4. Market Attractiveness Analysis, by Application

8. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Region
    8.1. Key Findings
    8.2. Market Value Forecast, by Region, 2017–2031
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Market Attractiveness Analysis, by Region

9. North America Bovine Blood Plasma Derivatives Market Analysis and Forecast
    9.1. Introduction
    9.2. Key Findings
    9.3. Market Value Forecast, by Derivative Type, 2017–2031
        9.3.1. Immunoglobulin
        9.3.2. Fibrinogen
        9.3.3. Bovine Serum Albumin
        9.3.4. Fetal Bovine Serum
        9.3.5. Thrombin
        9.3.6. Transferrin
        9.3.7. Newborn Calf Serum
        9.3.8. Others
    9.4. Market Value Forecast, by Application, 2017–2031
        9.4.1. Pharmaceutical Industry
        9.4.2. Diagnostics Industry
        9.4.3. Cell Culture/ Biotechnology
        9.4.4. Research and Development
        9.4.5. Food Industry
        9.4.6. Cosmetic Industry
        9.4.7. Others
    9.5. Market Value Forecast, by Country, 2017–2031
        9.5.1. U.S.
        9.5.2. Canada
    9.6. Market Attractiveness Analysis
        9.6.1. By Derivative Type
        9.6.2. By Application
        9.6.3. By Country

10. Europe Bovine Blood Plasma Derivatives Market Analysis and Forecast
    10.1. Introduction
    10.2. Key Findings
    10.3. Market Value Forecast, by Derivative Type, 2017–2031
        10.3.1. Immunoglobulin
        10.3.2. Fibrinogen
        10.3.3. Bovine Serum Albumin
        10.3.4. Fetal Bovine Serum
        10.3.5. Thrombin
        10.3.6. Transferrin
        10.3.7. Newborn Calf Serum
        10.3.8. Others
    10.4. Market Value Forecast, by Application, 2017–2031
        10.4.1. Pharmaceutical Industry
        10.4.2. Diagnostics Industry
        10.4.3. Cell Culture/ Biotechnology
        10.4.4. Research and Development
        10.4.5. Food Industry
        10.4.6. Cosmetic Industry
        10.4.7. Others
    10.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        10.5.1. Germany
        10.5.2. U.K.
        10.5.3. France
        10.5.4. Italy
        10.5.5. Spain
        10.5.6. Rest of Europe
    10.6. Market Attractiveness Analysis
        10.6.1. By Derivative Type
        10.6.2. By Application
        10.6.3. By Country/Sub-region

11. Asia Pacific Bovine Blood Plasma Derivatives Market Analysis and Forecast
    11.1. Introduction
    11.2. Key Findings
    11.3. Market Value Forecast, by Derivative Type, 2017–2031
        11.3.1. Immunoglobulin
        11.3.2. Fibrinogen
        11.3.3. Bovine Serum Albumin
        11.3.4. Fetal Bovine Serum
        11.3.5. Thrombin
        11.3.6. Transferrin
        11.3.7. Newborn Calf Serum
        11.3.8. Others
    11.4. Market Value Forecast, by Application, 2017–2031
        11.4.1. Pharmaceutical Industry
        11.4.2. Diagnostics Industry
        11.4.3. Cell Culture/ Biotechnology
        11.4.4. Research and Development
        11.4.5. Food Industry
        11.4.6. Cosmetic Industry
        11.4.7. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. China
        11.5.2. Japan
        11.5.3. India
        11.5.4. Australia & New Zealand
        11.5.5. Rest of Asia Pacific
    11.6. Market Attractiveness Analysis
        11.6.1. By Derivative Type
        11.6.2. By Application
        11.6.3. By Country/Sub-region
12. Latin America Bovine Blood Plasma Derivatives Market Analysis and Forecast
    12.1. Introduction
    12.2. Key Findings
    12.3. Market Value Forecast, by Derivative Type, 2017–2031
        12.3.1. Immunoglobulin
        12.3.2. Fibrinogen
        12.3.3. Bovine Serum Albumin
        12.3.4. Fetal Bovine Serum
        12.3.5. Thrombin
        12.3.6. Transferrin
        12.3.7. Newborn Calf Serum
        12.3.8. Others
    12.4. Market Value Forecast, by Application, 2017–2031
        12.4.1. Pharmaceutical Industry
        12.4.2. Diagnostics Industry
        12.4.3. Cell Culture/ Biotechnology
        12.4.4. Research and Development
        12.4.5. Food Industry
        12.4.6. Cosmetic Industry
        12.4.7. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. Brazil
        12.5.2. Mexico
        12.5.3. Rest of Latin America
    12.6. Market Attractiveness Analysis
        12.6.1. By Derivative Type
        12.6.2. By Application
        12.6.3. By Country/Sub-region
13. Middle East & Africa Bovine Blood Plasma Derivatives Market Analysis and Forecast
    13.1. Introduction
    13.2. Key Findings
    13.3. Market Value Forecast, by Derivative Type, 2017–2031
        13.3.1. Immunoglobulin
        13.3.2. Fibrinogen
        13.3.3. Bovine Serum Albumin
        13.3.4. Fetal Bovine Serum
        13.3.5. Thrombin
        13.3.6. Transferrin
        13.3.7. Newborn Calf Serum
        13.3.8. Others
    13.4. Market Value Forecast, by Application, 2017–2031
        13.4.1. Pharmaceutical Industry
        13.4.2. Diagnostics Industry
        13.4.3. Cell Culture/ Biotechnology
        13.4.4. Research and Development
        13.4.5. Food Industry
        13.4.6. Cosmetic Industry
        13.4.7. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. GCC Countries
        13.5.2. South Africa
        13.5.3. Rest of Middle East & Africa
    13.6. Market Attractiveness Analysis
        13.6.1. By Derivative Type
        13.6.2. By Application
        13.6.3. By Country/Sub-region
14. Competition Landscape
    14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
    14.2. Market Share Analysis, by Company (2022)
    14.3. Company Profiles
        14.3.1. Merck KGaA
            14.3.1.1. Company Overview
            14.3.1.2. Product Portfolio
            14.3.1.3. SWOT Analysis
            14.3.1.4. Financial Overview
            14.3.1.5. Strategic Overview
        14.3.2. LAMPIRE Biological Laboratories, Inc.
            14.3.2.1. Company Overview
            14.3.2.2. Product Portfolio
            14.3.2.3. SWOT Analysis
            14.3.2.4. Financial Overview
            14.3.2.5. Strategic Overview
        14.3.3. Proliant Health & Biologicals
            14.3.3.1. Company Overview
            14.3.3.2. Product Portfolio
            14.3.3.3. SWOT Analysis
            14.3.3.4. Financial Overview
            14.3.3.5. Strategic Overview
        14.3.4. Rocky Mountain Biologicals
            14.3.4.1. Company Overview
            14.3.4.2. Product Portfolio
            14.3.4.3. SWOT Analysis
            14.3.4.4. Financial Overview
            14.3.4.5. Strategic Overview
        14.3.5. Bovogen Biologicals Pty Ltd.
            14.3.5.1. Company Overview
            14.3.5.2. Product Portfolio
            14.3.5.3. SWOT Analysis
            14.3.5.4. Financial Overview
            14.3.5.5. Strategic Overview
        14.3.6. Thermo Fisher Scientific, Inc.
            14.3.6.1. Company Overview
            14.3.6.2. Product Portfolio
            14.3.6.3. SWOT Analysis
            14.3.6.4. Financial Overview
            14.3.6.5. Strategic Overview
        14.3.7. Kraeber & Co GmbH
            14.3.7.1. Company Overview
            14.3.7.2. Product Portfolio
            14.3.7.3. SWOT Analysis
            14.3.7.4. Financial Overview
            14.3.7.5. Strategic Overview
        14.3.8. Auckland BioSciences Ltd.
            14.3.8.1. Company Overview
            14.3.8.2. Product Portfolio
            14.3.8.3. SWOT Analysis
            14.3.8.4. Financial Overview
            14.3.8.5. Strategic Overview
        14.3.9. Lake Immunogenics, Inc.
            14.3.9.1. Company Overview
            14.3.9.2. Product Portfolio
            14.3.9.3. SWOT Analysis
            14.3.9.4. Financial Overview
            14.3.9.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031

Figure 03: Global Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031

Figure 04: Global Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application 2022 and 2031

Figure 05: Global Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

Figure 06: Global Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

Figure 07: Global Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

Figure 08: Global Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Region, 2022 and 2031

Figure 09: Global Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Region, 2023–2031

Figure 10: North America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031

Figure 11: North America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031

Figure 12: North America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031

Figure 13: North America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

Figure 14: North America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

Figure 15: North America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

Figure 16: North America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

Figure 17: North America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country, 2022 and 2031

Figure 18: North America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country, 2023–2031

Figure 19: Europe Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031

Figure 20: Europe Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031

Figure 21: Europe Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031

Figure 22: Europe Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

Figure 23: Europe Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

Figure 24: Europe Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

Figure 25: Europe Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

Figure 26: Europe Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 27: Europe Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 28: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031

Figure 29: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031

Figure 30: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031

Figure 31: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application 2022 and 2031

Figure 32: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

Figure 33: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

Figure 34: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

Figure 35: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 36: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 37: Latin America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031

Figure 38: Latin America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031

Figure 39: Latin America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031

Figure 40: Latin America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

Figure 41: Latin America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

Figure 42: Latin America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

Figure 43: Latin America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

Figure 44: Latin America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 45: Latin America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 46: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031

Figure 47: Middle East & Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031

Figure 48: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031

Figure 49: Middle East & Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

Figure 50: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

Figure 51: Middle East & Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031

Figure 52: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031

Figure 53: Middle East & Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 54: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 55: Global Africa Bovine Blood Plasma Derivatives Market Share Analysis, by Company, 2022

List of Tables

List of Tables

Table 01: Global Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031

Table 02: Global Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031

Table 03: Global Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 04: Global Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 05: Global Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 06: North America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031

Table 07: North America Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031

Table 08: North America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 09: North America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 10: North America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 11: Europe Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031

Table 12: Europe Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031

Table 13: Europe Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 14: Europe Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 15: Europe Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031

Table 17: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031

Table 18: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 19: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 20: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 21: Latin America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031

Table 22: Latin America Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031

Table 23: Latin America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 24: Latin America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 25: Latin America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031

Table 27: Middle East & Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031

Table 28: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 29: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 30: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031